Biological evaluation of a new family of aminosteroids that display a selective toxicity for various malignant cell lines

Anti-cancer Drugs
Hajer JeghamDonald Poirier

Abstract

This study investigated the antineoplasic potential of a new family of aminosteroids. The antiproliferative activity of seven 5α-androstane-3α,17β-diol derivatives selected from a screening study was measured on nine cancerous cell lines (HL-60, K-562, LNCaP, PC-3, Shionogi, MCF-7, MDA-MB-231, BT-20, and OVCAR-3) and two normal cell lines (peripheral blood lymphocytes and WI-38). The aminosteroids efficiently inhibited the cell growth of seven cancer cell lines [inhibitory concentration (IC(50)) values=0.2-6.4 µmol/l] and showed weak toxicity on normal cell lines. Two representative aminosteroids were tested and found to induce apoptosis and a G0/G1 cell cycle block in HL-60-treated cells, but not terminal myeloid differentiation. By a nuclear morphology analysis with fluorescence microscopy, typical apoptotic morphological changes were exhibited by treated cells. One aminosteroid tested in vivo (xenograft model) reduced the breast cancer (MCF-7 cells) tumor growth induced in nude mice. Furthermore, the information gathered suggests that this family of aminosteroids induced growth inhibition cells by arresting the cell cycle and triggering apoptosis.

References

Mar 23, 2000·International Journal of Cancer. Journal International Du Cancer·M H AhonenP Tuohimaa
Jul 11, 2001·Immunologic Research·N J Olsen, W J Kovacs
Jun 12, 2003·American Journal of Reproductive Immunology : AJRI·T ThongngarmR W McMurray
Jan 24, 2004·Apoptosis : an International Journal on Programmed Cell Death·A ThorburnA E Frankel
Jan 30, 2004·Cancer Immunology, Immunotherapy : CII·Klaus-Michael Debatin
May 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·A McLachlanS Pandey
Jul 26, 2005·Annals of Hematology·Katrien VermeulenZwi N Berneman
Feb 7, 2006·Mini Reviews in Medicinal Chemistry·Donald Poirier, René Maltais
Jul 11, 2006·Life Sciences·Danilo Damasceno RochaLetícia Veras Costa-Lotufo
Sep 15, 2006·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Daniel Pereira BezerraLetícia Veras Costa-Lotufo
Dec 27, 2008·Free Radical Biology & Medicine·Defang LiJi Li
Mar 18, 2009·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·M C HeinrichM Uder
Aug 4, 2009·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Henk J BroxtermanHenk M W Verheul
Jun 15, 2010·Immunology Letters·Marina PierdominiciElena Ortona

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.